10X GENOMICS INC-CLASS A (TXG:NASDAQ)
$68.59 2.21 (3.3293%)
Analysed 10X GENOMICS INC-CLASS A (TXG:NASDAQ) News Sources
10x Genomics (TXG) Q2 2026 Earnings Call Transcript
14-08-2026
fool.com
5 Revealing Analyst Questions From 10x Genomics’s Q2 Earnings Call
15-08-2026
yahoo.com
10x Genomics (TXG) Sees Strong Early Orders for New Atera Platform
18-08-2026
yahoo.com
3 Small-Cap Stocks with Open Questions
25-08-2026
yahoo.com
10x Genomics Wins Patent Infringement Verdict Against Parse Biosciences
28-08-2026
yahoo.com
TXG Stock Down Despite Patent Verdict Win Against Parse Biosciences
31-08-2026
yahoo.com
10x Genomics Needs "Meaningful' Growth in Single-Cell Business, RBC Says
01-09-2026
yahoo.com
10x Genomics Rallies 84% in 3 Months: Is There More Upside Ahead?
03-09-2026
yahoo.com
Multiomics Market Report Now Available — See Why Spatial Omics Is Set to Outgrow Single-Cell as the Field's Next Growth Driver
08-09-2026
yahoo.com
Transcriptome Sequencing Market - Global Forecast to 2035; Bulk RNA-Seq Maintains Its Technology Market Lead
10-09-2026
yahoo.com
What is the current price of 10X GENOMICS INC-CLASS A (TXG:NASDAQ)?
The current price of 10X GENOMICS INC-CLASS A (TXG:NASDAQ) is $68.59.
10X GENOMICS INC-CLASS A (TXG:NASDAQ) absolute price change since previous trading day?
The absolute price change of 10X GENOMICS INC-CLASS A (TXG:NASDAQ) since the previous trading day is $2.21.
10X GENOMICS INC-CLASS A (TXG:NASDAQ) percentage price change since previous trading day?
The percentage price change of 10X GENOMICS INC-CLASS A (TXG:NASDAQ) since the previous trading day is 3.3293%.
What is the most recent average sentiment score for 10X GENOMICS INC-CLASS A (TXG:NASDAQ)?
The most recent average sentiment score for 10X GENOMICS INC-CLASS A (TXG:NASDAQ) is 49 out of 100.
What is the most recent average sentiment for 10X GENOMICS INC-CLASS A (TXG:NASDAQ)?
The most recent sentiment for 10X GENOMICS INC-CLASS A (TXG:NASDAQ) is .
SEC-8K** Filing Available For 10X GENOMICS INC-CLASS A (TXG:NASDAQ)
** material developments that could impact a company's financial condition or stock price.
Author: MattELab
MattELab is the founder and lead developer of SentientMerchant. With a Computer Science and Quantitative Finance background from a T10 university, he brings over 6 years of expertise in NLP, programmatic SEO, and full-stack development to build highly scalable AI and FinTech solutions.